| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |